PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2009 | 5 | 84-87
Article title

Personalised medicine and its role in new drugs development

Title variants
Languages of publication
PL
Abstracts
EN
Personalized medicine is coming step by step to real clinical practice. The new era is forthcoming, in which 'one size does not fit all'. The hopes and expectations predominantly are based on achievements of molecular biology. Close connection between therapy and corresponding diagnostic test can lead to better defining patients target groups. Moreover, biomarkers defining is becoming a new approach to therapy stratification. Viral, oncologic, inflammatory and metabolic diseases are the examples of Roche involvement in this strategic way of development.
Keywords
EN
Publisher

Journal
Year
Issue
5
Pages
84-87
Physical description
Contributors
author
author
References
Document Type
MONOGRAPHY
Publication order reference
Claudia Schmitt, Hoffmann-La Roche Ltd, Basel
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-7807f54d-51f1-3c1d-974a-609f4325f82d
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.